- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05727150
Reliability and Versatility of Supraclavicular Artery Flap in Reconstruction of Head and Neck Soft Tissue Defects
February 3, 2023 updated by: Ahmad Ahmad Albadry, Sohag University
This is a case series study conducted at plastic surgery department Sohag University including 20 patients The aim of this thesis is to evaluate reliability and versatility of Supraclavicular artery flap in the reconstruction of traumatic and non-traumatic defects of head and neck.With adequate documentation of functional, aesthetic outcome and patient satisfaction through; clinical examination , photographic documentation and doctor and patient satisfaction charts
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ahmad A Albadry
- Phone Number: 20111088856
- Email: ahmedahmed@med.sohag.edu.eg
Study Contact Backup
- Name: Karam A Mohammed
- Phone Number: 201021777543
- Email: Karam.allam@med.sohag.edu.eg
Study Locations
-
-
-
Sohag, Egypt
- Recruiting
- Sohag Faculty of Medicine
-
Contact:
- Karam A Mohammed
- Phone Number: 201021777543
- Email: Karam.allam@med.sohag.edu.eg
-
Contact:
- Ahmad A Albadry
- Phone Number: 201110884856
- Email: ahmedahmed@med.sohag.edu.eg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 75 years (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with head and neck soft tissue defect either traumatic or non-traumatic
- Available healthy donor site
Exclusion Criteria:
- Trauma or conditions affecting donor site or with possible compromise of vascular pedicle.
- Patients with a major uncontrollable medical illness, chronic heavy smokers.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Patient operated by Supraclavicular Artery flap for Reconstruction
Supraclavicular artery flap will be used for reconstruction
|
Supraclavicular artery flap will be used in the reconstruction of traumatic and non-traumatic defects of head and neck.Flap harvesting and reconstruction will be performed under general anesthesia.
The defect dimensions are measured and the superficial landmarks for the supraclavicular artery are drawn .The flap will be used as island flap, transposed or interpolated flap depending on the arc of rotation needed to achieve flap inset without tension and flap elevation proceeds from lateral to medial.The flap is rotated and inset into the defect
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Flap Success
Time Frame: 6 month post-surgery
|
The flap success will be measured by percentage of patients in which there is flap survival versus percentage of patient with flap necrosis
|
6 month post-surgery
|
Flap complications
Time Frame: 6 months post-surgery
|
assessment of flap complication will be assessed by percentage of patients in which there is flap dehiscence , flap infection and flap necrosis
|
6 months post-surgery
|
patients satisfaction as regard flap color match
Time Frame: 6 months post-surgery
|
patient satisfaction as will be assessed with questionnaire
|
6 months post-surgery
|
patients satisfaction as regard flap texture match
Time Frame: 6 months post-surgery
|
patient satisfaction as will be assessed with questionnaire
|
6 months post-surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Possible flap lengths
Time Frame: 6 months post-surgery
|
The achieved flap length will be measured in centimeters
|
6 months post-surgery
|
Possible flap widths
Time Frame: 6 months post-surgery
|
The achieved flap width will be measured in centimeters
|
6 months post-surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ahmad A Albadry, Sohag University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
February 1, 2023
Primary Completion (ANTICIPATED)
July 1, 2023
Study Completion (ANTICIPATED)
January 1, 2024
Study Registration Dates
First Submitted
January 22, 2023
First Submitted That Met QC Criteria
February 3, 2023
First Posted (ESTIMATE)
February 14, 2023
Study Record Updates
Last Update Posted (ESTIMATE)
February 14, 2023
Last Update Submitted That Met QC Criteria
February 3, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- Soh-Med-23-01-03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Reconstruction of Head Soft Tissue Defects
-
The Second Hospital of TangshanChinese PLA General HospitalCompletedSoft Tissue Defect | Sensory Reconstruction of Digits | Multiple Digital DefectsChina
-
Aswan UniversityRecruitingCoverage of Soft Tissue DefectsEgypt
-
The Second Hospital of TangshanCompletedSensory Restoration | Soft Tissue ReconstructionChina
-
Masaryk Memorial Cancer InstituteUnknownMalignant Tumor of Soft Tissue of Head, Face and NeckCzechia
-
Sohag UniversityNot yet recruitingSOFT TISSUE DEFECTSEgypt
-
Integra LifeSciences CorporationGeorgetown UniversityCompletedComplex Lower Extremity Soft Tissue ReconstructionUnited States
-
Hacettepe UniversityCompletedTo Evaluate the Efficacy of Platelet-rich Fibrin in Papilla Reconstruction | To Evaluate the Efficacy of Connective Tissue Graft in Papilla ReconstructionTurkey
-
AO Innovation Translation CenterRecruitingMandibular Reconstruction | Segmental Mandibular DefectsGermany, Switzerland, United States, Netherlands, Sweden, Spain
-
University of MichiganBioHorizons, Inc.CompletedDental Implant Soft Tissue Defects in the Anterior MaxillaUnited States
-
Fudan UniversityUnknownLocal Recurrence of Malignant Tumor of Soft TissueChina
Clinical Trials on Reconstruction of Soft tissue defects of head and neck by Supraclavicular artery flap
-
Maha Samy ElhadidyCairo UniversityUnknownOral Soft Tissue Conditions
-
Vanderbilt UniversityTerminated
-
Ottawa Hospital Research InstituteUnknown
-
Ain Shams UniversityCompleted
-
European Organisation for Research and Treatment...Gruppo Italiano Malattie EMatologiche dell'AdultoUnknown
-
Erzhen ChenRenJi HospitalUnknownPancreatitis,Acute NecrotizingChina
-
Stanford UniversityCompletedLeukemia | Blood CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGlioblastoma | GliosarcomaUnited States
-
Case Comprehensive Cancer CenterCompletedRecurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditionsUnited States